Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment

Eva Louwersheimer¹, Steffen Wolfsgruber², Ana Espinosa³, André Lacour⁴, Stefanie Heilmann-Heimbach⁵, Montserrat Alegret³, Isabel Hernández³, Maitée Rosende-Roca³, Lluís Tárraga³, Mercè Boada³, Johannes Kornhuber⁶, Oliver Peters⁷, Lutz Frölich⁸, Michael Hüll⁹, Eckart Rüther¹⁰, Jens Wiltfang¹⁰, Martin Scherer¹¹, Steffi Riedel-Heller¹², Frank Jessen¹³, Markus M Nöthen⁵, Wolfgang Maier², Ted Koene¹⁴, Philip Scheltens¹⁵, Henne Holstege¹⁶, Michael Wagner², Agustín Ruiz³, Wiesje M van der Flier¹⁷, Tim Becker¹⁸, Alfredo Ramirez¹⁹

Affiliations

¹ Alzheimer Center and Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands. Electronic address: e.louwersheimer@vumc.nl.
² Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
³ Alzheimer Research Center and Memory Clinic of Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain.
⁴ German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
⁵ Institute of Human Genetics, University of Bonn, Bonn, Germany; Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
⁶ Department of Psychiatry and Psychotherapy, University Clinic Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
⁷ Department of Psychiatry, Charité University Medicine, Berlin, Germany.
⁸ Department of Geriatric Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
⁹ Centre for Geriatric Medicine and Section of Gerontopsychiatry and Neuropsychology, Medical School, University of Freiburg, Freiburg, Germany.
¹⁰ Department of Psychiatry and Psychotherapy, University of Göttingen, Göttingen, Germany.
¹¹ Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
¹² Institute of Social Medicine, Occupational Health and Public Health, University of Leipzig, Leipzig, Germany.
¹³ Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany.
¹⁴ Alzheimer Center and Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands; Alzheimer Center and Department of Medical Psychology, VU University Medical Center, Amsterdam, The Netherlands.
¹⁵ Alzheimer Center and Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands.
¹⁶ Alzheimer Center and Department of Clinical Genetics, Neuroscience Campus Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands.
¹⁷ Alzheimer Center and Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands; Department of Epidemiology & Biostatistics, VU University Medical Center, Amsterdam, The Netherlands.
¹⁸ Institute for Community Medicine, Ernst Moritz Arndt University Greifswald, Greifswald, Germany.
¹⁹ Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany; Institute of Human Genetics, University of Bonn, Bonn, Germany. Electronic address: alfredo.ramirez@ukb.uni-bonn.de.

PMID: 26921674
DOI: 10.1016/j.jalz.2016.01.006

Free article

Meta-Analysis

Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment

Eva Louwersheimer et al. Alzheimers Dement. 2016 Aug.

Free article

. 2016 Aug;12(8):872-81.

doi: 10.1016/j.jalz.2016.01.006. Epub 2016 Feb 26.

Authors

Affiliations

¹ Alzheimer Center and Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands. Electronic address: e.louwersheimer@vumc.nl.
² Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
³ Alzheimer Research Center and Memory Clinic of Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain.
⁴ German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
⁵ Institute of Human Genetics, University of Bonn, Bonn, Germany; Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
⁶ Department of Psychiatry and Psychotherapy, University Clinic Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
⁷ Department of Psychiatry, Charité University Medicine, Berlin, Germany.
⁸ Department of Geriatric Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
⁹ Centre for Geriatric Medicine and Section of Gerontopsychiatry and Neuropsychology, Medical School, University of Freiburg, Freiburg, Germany.
¹⁰ Department of Psychiatry and Psychotherapy, University of Göttingen, Göttingen, Germany.
¹¹ Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
¹² Institute of Social Medicine, Occupational Health and Public Health, University of Leipzig, Leipzig, Germany.
¹³ Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany.
¹⁴ Alzheimer Center and Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands; Alzheimer Center and Department of Medical Psychology, VU University Medical Center, Amsterdam, The Netherlands.
¹⁵ Alzheimer Center and Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands.
¹⁶ Alzheimer Center and Department of Clinical Genetics, Neuroscience Campus Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands.
¹⁷ Alzheimer Center and Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands; Department of Epidemiology & Biostatistics, VU University Medical Center, Amsterdam, The Netherlands.
¹⁸ Institute for Community Medicine, Ernst Moritz Arndt University Greifswald, Greifswald, Germany.
¹⁹ Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany; Institute of Human Genetics, University of Bonn, Bonn, Germany. Electronic address: alfredo.ramirez@ukb.uni-bonn.de.

PMID: 26921674
DOI: 10.1016/j.jalz.2016.01.006

Abstract

Introduction: We evaluated the effect of Alzheimer's disease (AD) susceptibility loci on endophenotypes closely related with AD pathology in patients with mild cognitive impairment (MCI).

Methods: We selected 1730 MCI patients from four independent data sets. Weighted polygenic risk scores (PGS) were constructed of 18 non-apolipoprotein E (APOE) AD risk variants. In addition, we determined APOE genotype. AD endophenotypes were cognitive decline over time and cerebrospinal fluid (CSF) biomarkers (aβ, tau, ptau).

Results: PGS was modestly associated with cognitive decline over time, as measured by mini-mental state examination (MMSE) (β ± SE:-0.24 ± 0.10; P = .012), and with CSF levels of tau and ptau (tau: 1.38 ± 0.36, P = 1.21 × 10(-4); ptau: 1.40 ± 0.36, P = 1.02 × 10(-4)).

Discussion: In MCI, we observed a joint effect of AD susceptibility loci on nonamyloid endophenotypes, suggesting a link of these genetic loci with neuronal degeneration in general rather than with Alzheimer-related amyloid deposition.

Keywords: Alzheimer's disease; Endophenotypes; Genetic risk variants; Mild cognitive impairment; Polygenic risk score.

PubMed Disclaimer

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment

Affiliations

Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment

Authors

Affiliations

Abstract

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous